Search Clinical Trials
By Condition
By Location (USA)
By Location (Other)
By Sponsor
Resources
Privacy Policy
About Us
Disclaimer
Study of Genetic and Molecular Defects in Primary Immunodeficiency Disorders Clinical Trials Resources presented on Clinical Trials Search isn't meant to be a substitute for qualified health advice, visits or professional assistance with a real medical. We aren't doctors. Always consult your mD about Study of Genetic and Molecular Defects in Primary Immunodeficiency Disorders conditions. Clinical Trials Search.org is a website dedicated to listing clinical research studies in human subjects. Study of Genetic and Molecular Defects in Primary Immunodeficiency Disorders Clinical research trials and Study of Genetic and Molecular Defects in Primary Immunodeficiency Disorders health trials occur in a lot of of places throughout the United States of America. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials typically assess the effectivity of new does drugs. The role of the studies / projects is to resolve certain human healthcare questions. Clinical trials are a popular way for doctors, government agencies, and private sector corporations to detect remedies for all varieties of circumstances, such as Study of Genetic and Molecular Defects in Primary Immunodeficiency Disorders. Study of Genetic and Molecular Defects in Primary Immunodeficiency Disorders Clinical Trials and other clinical trials allow volunteers to obtain health treatment choices before they are available to the general public. Most times the human subjects recieve professional assistance for free of charge, and every now and again they are paid for their time. Sometimes there is a cost for a Study of Genetic and Molecular Defects in Primary Immunodeficiency Disorders clinical trial. Human subjects frequently get the finest healthcare available for their Study of Genetic and Molecular Defects in Primary Immunodeficiency Disorders condition. Risks are a reality, however, and may include extra or frequent physician visits, medical dangers (possibly life-threatening), and/or the treatment being uneffective. Trials are federally governed with strict guidelines to protect clinical trials patients.

Home > "S" Clinical Trials Conditions > Study of Genetic and Molecular Defects in Primary Immunodeficiency Disorders

Study of Genetic and Molecular Defects in Primary Immunodeficiency Disorders



Study of Genetic and Molecular Defects in Primary Immunodeficiency Disorders

For Condition: X-linked hyper IgM syndrome,X-linked agammaglobulinemia,Wiskott-Aldrich Syndrome,Leukocyte Adhesion Deficiency Syndrome
Status: No longer recruiting
Sponsor(s): National Institute of Child Health and Human Development (NICHD) , University of Washington
Synopsis: OBJECTIVES: I. Identify the molecular defects responsible for primary immunodeficiency disorders. II. Explore the mutations within each syndrome to better understand the genetics of these disorders. III. Study the function of the Wiskott-Aldrich syndrome proteins (WASP). IV. Design methods to identify carriers and for prenatal diagnosis. V. Explore new avenues for therapy.
Details: PROTOCOL OUTLINE: Patients are studied systematically to determine the extent of their immune deficiency and to confirm a specific diagnosis. Patients with a known immunodeficiency syndrome are studied in detail to identify the gene mutation, to assess the effect of the mutation on the gene product, and to establish cell lines for further in vitro assessment of the genetic defect. The function of Wiskott-Aldrich syndrome proteins (WASP) in hematopoietic cells is studied. Family members of patients with X-linked disorders are studied to identify carrier females.
Eligibility:
Study Type:
  Observational, Screening
Minimum Age/Maximum Age: /
Genders: Both
Protocol Entry Criteria: PROTOCOL ENTRY CRITERIA: Primary immunodeficiency disease, e.g.: Leukocyte adhesion deficiency syndrome Wiskott-Aldrich syndrome X-linked agammaglobulinemia X-linked hyper IgM syndrome
Total Enrollment: 

Location and Contact Information:

Overall Study Official:
HansOchs,  Study Chair,  University of Washington

University of Washington School of Medicine
Seattle,  Washington,  98195
United States
 


Additional Information:
Study ID Numbers:
  199/11900;  UW-533
Study Start Date: July 1995
Record last reviewed: October 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00004341

Other Leukocyte Adhesion Deficiency Syndrome Studies:
1. Allogeneic Bone Marrow Transplantation in Patients With Primary Immunodeficiencies

2. Study of Genetic and Molecular Defects in Primary Immunodeficiency Disorders

Related Studies:

Other Leukocyte Adhesion Deficiency Syndrome Clinical Trials
Other Washington Clinical Trials
Other Seattle Clinical Trials

Study of Genetic and Molecular Defects in Primary Immunodeficiency Disorders

Modify your Search

  Other Leukocyte Adhesion Deficiency Syndrome Clinical Trials
  Other Washington Clinical Trials
  Other Seattle Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103